About Caribou Biosciences, Inc. 
Caribou Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 49 Schemes (21.13%)
Foreign Institutions
Held by 64 Foreign Institutions (9.49%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-54 Million
Pharmaceuticals & Biotechnology
USD 169 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.09
-86.55%
1.01






